StockData
Autolus Therapeutics plc logo

Autolus Therapeutics plc (AUTL) stock

AUTLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3020% below fair value
$1.06−0.03 (-2.75%)

Close on Nov 18, 2026Market cap $282.13MP/E –Yield –

Autolus Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Autolus Therapeutics's market cap was $328.69M on Nov 11, 2026, against $375.28M a year earlier. Over the last 5 years it ranged from $136.96M to $1.11B, with a median of $399.21M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$328.69M-37.9%
2025Dec 31, 2025$529.64M-2.9%
2024Dec 31, 2024$545.42M-46.1%
2023Dec 29, 2023$1.01B+638.9%
2022Dec 30, 2022$136.96M-51.8%
2021Dec 31, 2021$283.89M+0.6%
2020Dec 31, 2020$282.12M-32.3%
2019Dec 31, 2019$416.55M-59.8%
2018Dec 31, 2018$1.04B–

More Autolus Therapeutics figures

See a number that looks wrong?